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Skeletal muscle membrane lipid composition is related to adiposity and insulin
action
Abstract
The cellular basis of insulin resistance is still unknown, however, relationships have been demonstrated
between insulin action in muscle and the fatty acid profile of the major membrane structural lipid
(phospholipid). The present study aimed to further investigate the hypothesis that insulin action and
adiposity are associated with changes in the structural lipid composition of the cell. In 52 adult male
Pima Indians, insulin action (euglycemic clamp), percentage body fat (pFAT; underwater weighing), and
muscle phospholipid fatty acid composition (percutaneous biopsy of vastus lateralis) were determined.
Insulin action (high-dose clamp; MZ) correlated with composite measures of membrane unsaturation (%
C20-22 polyunsaturated fatty acids [r = 0.463, P < 0.001], unsaturation index [r = -0.369, P < 0.01]), a
number of individual fatty acids and with ??5 desaturase activity (r = 0.451, P < 0.001). pFAT (range
14-53%) correlated with a number of individual fatty acids and ??5 desaturase activity (r = -0.610, P <
0.0001). Indices of elongase activity (r = -0.467, P < 0.001), and ??9 desaturase activity (r = 0.332, P <
0.05) were also related to pFAT but not insulin action. The results demonstrate that ??5 desaturase
activity is independently related to both insulin resistance and obesity. While determining the
mechanisms underlying this relationship is important for future investigations, strategies aimed at
restoring 'normal' enzyme activities, and membrane unsaturation, may have therapeutic importance in the
'syndromes of insulin resistance.'
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Skeletal Muscle Membrane Lipid Composition Is Related to Adiposity and
Insulin Action
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and L. H. Storlienil
tDepartment of Endocrinology, Royal Prince Alfred Hospital, Sydney NSW 2050, Australia; §Clinical Diabetes
NIDDK NIH, Phoenix, Arizona 85016; and IlDepartment of Biomedical Science, University of Wollongong,
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Abstract
The cellular basis of insulin resistance is still unknown, however, relationships have been demonstrated between insulin
action in muscle and the fatty acid profile of the major
membrane structural lipid (phospholipid). The present
study aimed to further investigate the hypothesis that insulin
action and adiposity are associated with changes in the
structural lipid composition of the cell. In 52 adult male
Pima Indians, insulin action (euglycemic clamp), percentage body fat (pFAT; underwater weighing), and muscle
phospholipid fatty acid composition (percutaneous biopsy
of vastus lateralis) were determined. Insulin action (highdose clamp; MZ) correlated with composite measures of
membrane unsaturation (% C20-22 polyunsaturated fatty
acids [r = 0.463, P < 0.001], unsaturation index [r = -0.369,
P < 0.01]), a number of individual fatty acids and with A5
desaturase activity (r = 0.451, P < 0.001). pFAT (range
14-53% ) correlated with a number of individual fatty acids
and A5 desaturase activity (r = -0.610, P < 0.0001). Indices of elongase activity (r = -0.467, P < 0.001), and A9
desaturase activity (r = 0.332, P < 0.05) were also related
to pFAT but not insulin action. The results demonstrate
that A5 desaturase activity is independently related to both
insulin resistance and obesity. While determining the mechanisms underlying this relationship is important for future
investigations, strategies aimed at restoring "normal" enzyme activities, and membrane unsaturation, may have
therapeutic importance in the "syndromes of insulin resistance." (J. Clin. Invest. 1995. 96:2802-2808.) Key words:
dietary fats * euglycemic clamp * body composition * elongase activity * desaturase activity

Introduction
Impaired insulin action (insulin resistance) is central to a cluster
of prevalent diseases including non-insulin-dependent diabetes

and

Nutrition Section,

mellitus (NIDDM),' obesity, hypertension, dyslipidemias and
cardiovascular disease ( 1-3 ). However, the basic mechanisms
underlying insulin resistance are not known.
Skeletal muscle is the primary site of insulin stimulated
glucose disposal at euglycemia (4, 5). Recently, a relationship
between the fatty acid composition of skeletal muscle membrane structural lipid (phospholipid) and measures of insulin
resistance have been demonstrated in both experimental animals
and humans (6-8). This has demonstrated that the greater the
percentage of polyunsaturated fatty acids (PUFA) in muscle
membranes, the better the insulin action. With the exception of
some marine oils, dietary fats must be desaturated and elongated
to become the long-chain PUFA of muscle membranes. The
enzymes involved in these transformations, that we have focussed on in this paper, include: L.9 desaturase, which inserts
a double bond at the ninth carbon from the carboxyl terminal;
/\5 desaturase, which inserts a double bond at the fifth carbon
from the carboxyl terminal; and the ubiquitous elongase enzyme, which inserts two carbon units at the carboxy terminal
of the fatty acid (9). How these factors relate to insulin action
or to body composition, which itself is related to insulin resistance, has not been fully explored.
There is an emerging body of evidence to suggest that dietary fat profile is a determining factor in weight gain and
adiposity (10-13). Dietary fat content has been shown to act
at the molecular level, having a direct effect on gene expression
including both hepatic lipogenesis (14) and desaturase activity (15).
The present study was aimed at investigating the relationship between insulin action and adiposity and the structural lipid
composition of the cell membrane. The results demonstrate that
both impaired insulin action and obesity are independently associated with reduced z\5 desaturase activity. In contrast, increased adiposity was additionally found to be associated with
reduced elongase activity and higher A9 desaturase activity.

Methods
Aspects of these data were reported at the 1993 meeting of the North
American Association for the Study of Obesity.
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Subjects. Individuals in this study were 52 male volunteer Pima Indians
of the Gila River Indian Community who were participating in a longitudinal study of the development of NIDDM (16). The metabolic studies
were performed in the clinical research unit of the National Institutes
of Health (NIH) in Phoenix, Arizona. Subjects were 44 years of age

1. Abbreviations used in this paper: C20-22 PUFA, the total percentage
of long chain PUFA with 2 20 carbon units; UI, the unsaturation index;
LFPIns, log 10 fasting plasma insulin; M, low-dose in vivo insulin
mediated glucose disposal rate; MZ, high-dose in vivo insulin mediated
glucose disposal rate; NIDDM, non-insulin-dependent diabetes mellitus; PUFA, polyunsaturated fatty acids.

or younger and in good health as assessed by medical history and
physical examination. The current analysis was limited to individuals
with a mean fasting plasma glucose concentration of less than 7.8 mM.
Subject characteristics are listed in Table I. All subjects gave informed
consent, and the studies were approved by the ethics committees of the

NIH, the Indian Health Service and the Gila River Indian Community.
Upon admission to the clinical research unit, all subjects received
a weight maintenance diet consisting of 50% carbohydrate, 30% fat,
and 20% protein. A 75 gram oral glucose-tolerance test was performed
after .2 d on the diet and diabetes mellitus was diagnosed according to
World Health Organization criteria (17). At this base-line test, glucose
tolerance was normal in all but one subject who was marginally glucose
intolerant. Body composition (pFAT) was estimated by hydrodensitometry with simultaneous determination of lung residual volume (18, 19).
Euglycemic clamp. In vivo insulin-mediated glucose disposal rate
was measured by a two-step euglycemic-hyperinsulinemic clamp according to a modification of the method of DeFronzo et al. (20) which
has been described previously (21). The clamp was performed by a
primed continuous low- and high-dose insulin infusion (290 and 2900
pmol/min.m2 respectively) each of which were continued for 100 min
while the plasma glucose was maintained at - 5.5 mmol/liter. It is
unlikely that a true "steady state" is obtained during this length of
insulin infusion, although the glucose uptake approaches "steady state"
after 60 min. Nevertheless, the data does allow for relative comparisons
between individuals to be made. The physiology for its own sake is not
addressed and a pure "steady state" is not required for this analysis.
The in vivo insulin action was determined during the period from 60
to 100 min. Both the low-dose or physiological insulin stimulation level
(M) and high-dose or maximal insulin stimulation level (MZ) use the
units of mg/min.kg fat-free mass + 17.7 (22). Plasma glucose was
measured by the glucose oxidase method using a glucose analyzer
(Beckman Instruments, Inc., Fullerton, CA) and insulin concentrations

by radioimmunoassay using a radioassay analyzer (Concept 4; ICN,
Horsham, PA).
Indirect calorimetry. 40 min before the initial insulin infusion and
for the last 40 min of each insulin infusion, oxygen consumption and
carbon dioxide production were determined by open circuit indirect
calorimetry (23).
Muscle biopsy. 2 d after the euglycemic hyperinsulinemic clamp, a
percutaneous biopsy of the vastus lateralis muscle was obtained using
a Bergstrom needle (Depuy, Phoenix, AZ). The specimen was immediately frozen and stored in liquid nitrogen for later analysis.
Phospholipid fatty acid analysis. Extraction and derivatization of
the fatty acid components of muscle phospholipids has been described
elsewhere (12). In brief, muscle tissue was homogenized in 2:1(vol/
vol) chloroform:methanol and total lipid extracts prepared according to
Folch et al. (24). Phospholipids were isolated from less polar lipids by
solid-phase extraction on Sep-Pak silica cartridges (Waters, Milford,
MA). The phospholipids were transmethylated and the methyl fatty
acids separated, identified and quantitated by gas chromatography.
Fatty acid data analysis. The content of individual fatty acids in
the skeletal muscle phospholipids was expressed as a percentage of the
total fatty acids identified. (For a review on the nomenclature and function of the principal PUFA and their metabolic interconversions see
references 25 and 26). Two fatty acid indices were derived from the
primary data: the average degree of fatty acid unsaturation (the unsaturation index; UI), which was calculated as the average number of double
bonds per fatty acid residue multiplied by 100; and the total percentage
of long chain PUFA with 2 20 carbon units (C20-22 PUFA). The
activity of a number of the enzymes of fatty acid biosynthesis was
estimated according to the product precursor ratios of the percentage
of individual fatty acids. The estimated enzyme activities include: the
ubiquitous elongase, calculated from the ratio of the percentage of 18:0
(stearic acid) to 16:0 (palmitic acid); and the A5 desaturase, calculated
from the ratio of 20:4n-6 (arachidonic acid) to 20:3n-6; and L\9 desaturase, calculated from the ratio of 18:ln-9 (oleic acid) to 18:0.
Statistics. All data are expressed as the mean±SEM. All statistical
analyses were performed using Statview 512+ statistical package (Aba-

Table I. Subject Characteristics
Variable

Mean*

Minimum

Maximum

Age (years)
Height (cm)
Weight (kg)
Body Mass Index (wt/ht2)
Percent body fat
Waist/thigh (cm)
Fasting plasma glucose (mM)
Fasting plasma insulin (pM)
Total M (mg/min.kgFFM + 17.7)
Total MZ (mg/min.kgFFM + 17.7)

52
27.5±0.7
171.4±0.8
96.8±4.0
32.9±1.3
28±1
1.7±0.1
5.0±0.1
215±15
3.3±0.2
9.0±0.3

18.1
150.5
56.1
19.0
14
1.3
4.1
83
1.6
3.9

43.8
182.5
257.3
81.2
53
2.3
6.6
677
11.4
16.3

n

*

Values are mean±SEM.

cus Concepts Inc., Berkeley, CA). The relations between variables were
analyzed by both simple and multiple regression with significance determined by F value.

Results
Mean values and ranges obtained for body size and insulin
action are shown in Table I. The group is an overweight population as indicated by the mean BMI and pFAT of 32.9±1.3 and
28±1% respectively. The fatty acid profile of muscle phospholipids and correlations with fasting plasma insulin, clamp-derived M and MZ values, pFAT BMI and waist thigh ratio are
listed in Table II. The relationships between the metabolic determinants and derived fatty acid indices are presented in Table
III and the salient points are highlighted below.
Insulin action was significantly related to membrane phospholipid fatty acid proportions. This was true of measures of
insulin action reflected by fasting insulin (LFPIns), glucose
uptake at physiological insulin (M) or glucose uptake at supra
physiological (MZ; maximally stimulating) insulin concentrations (Table III). Measures of insulin action were well correlated with each other and with measures of obesity (Table III).
Similarly, measures of obesity were significantly correlated with
each other and to membrane phospholipid fatty acid proportions.
In contrast to these relationships, no significant relationships
were observed between values for either basal lipid (0.58
±0.03 mg/min.kg FFM; range 0.14-0.97) or carbohydrate
(1.65±0.07mg/min.kg FFM; range 0.70-3.10) oxidation and
any measure of insulin action or obesity.
Insulin action and fatty acid variables. As shown in Table
Ill, significant correlations were found between MZ and: (a)
the percentage of C20-22 PUFA; (b) A5 desaturase activity;
and (c) the composite measure of unsaturation, UI. Similarly,
insulin action at the low dose insulin infusion (M) was also
positively correlated with the percentage of C20-22 PUFA and
A5 desaturase activity (Fig. 1 a) but not UI.
Obesity and fatty acid variables. A number of individual
fatty acids and derived indices were significantly correlated with
measures of adiposity (Tables II and III). The A5 desaturase
activity, related strongly to measures of adiposity (Fig. 1 b) as
did the ratio 18:0/16:0, an index of elongase activity (Fig. 2).
Furthermore, a significant (P < 0.05) relationship was observed
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Table II. The Profile of Fatty Acids in the Phospholipid Fraction of Skeletal Muscle and Simple Correlations with Fasting Plasma
Insulin, Insulin Action Indices, Percentage Body Fat, Body Mass Index and Waist to Thigh Ratio
Variable

Mean*

LFPInst

Log MI

Log MZ11

pFATI

BMI**

Waist/thigh

16:0
18:0
16:1
18: 1n9
18:2n-6
20:3n-6
20:4n-6
22:5n-6
22:6:n-3

15.3±0.2
13.1±0.2
1.2±0.1
7.9±0.2
36.2±0.3
2.0±0.0
16.8±0.2
1.0±0.1
1.3±0.1

0.156
-0.092

-0.009
0.273
-0.263
-0.147
-0.201
-0.479c
0.292a
0.254
0.112

-0.094
0.117
-0.207
0.065
-0.297a
-0.266

0.334a
-0.286a
0.145
0.251
0.069

0.320a
-0.288a
0.201
0.189
0.121

0.153
-0.168
0.115
0.156
0.149

0.587d

0.391b

-0.322a
-0.024
-0.254

0.528d
-0.348"

-0.132

0.304a
0.062
0.199
0.444c

-0.416"
-0.299a
-0.101

0.314a
0.119

-0.081
-0.306a

0.400b
-0.401b
-0.298a

* Values are means±SEM expressed as a percentage of total fatty acids.
Log 10 of the fasting plasma insulin (pM). § LoglO of the low-dose
insulin-(290 pmol/min.m2) mediated glucose disposal rate (mg/min/kgFFM + 17.7). 1 LoglO of the high-dose insulin-(2900 pmol/min.m2) mediated
glucose disposal rate (mg/min/kgFFM + 17.7). 1 Percentage body fat determined by densitometry. ** Body mass index (wtAht2). a p < 0.05; b p
< 0.01; cP < 0.001; dp < 0.0001.

between percentage body fat and A9 desaturase activity ( 18: in9/18:0).
Insulin action and obesity. Measures of insulin action were
related to each other as well as to measures of obesity (Table
III). A5 desaturase activity was the only lipid variable that
correlated with all the measures of insulin action and all the
obesity measures (Table III).
Table IV shows possible permutations of the independent
relationships between A5, insulin action and adiposity. A5 related to LFPIns, M and MZ independent of pFAT, BMI and
waist/thigh. In turn, A5 related to pFAT and BMI but not waist
thigh ratio, independently of all three measures of insulin action.
The C20-22 PUFA and UI were related to insulin action
but not to any direct measure of adiposity or central adiposity
(Table HI). On the other hand elongase and A9 were significantly related to BMI and pFAT but not at all to insulin action
(Table III).

Discussion
The present study has demonstrated significant relationships
between skeletal muscle membrane phospholipid fatty acid

composition and both insulin action and adiposity in a population with the highest reported incidence of NIDDM in the world.
Diabetes mellitus in this discrete population has been extensively characterized and roles for obesity, insulin receptor and
post receptor function, insulin resistance, family history and
genetic make-up in NIDDM have been determined (16, 2733). The initial lesion that leads to diabetes in this population
appears to be insulin resistance in skeletal muscle and possibly
liver. The current studies relating obesity, insulin action and
membrane phospholipid were performed in a search for possible
underlying mechanisms for these previous clinical observations.
These studies extend earlier findings in Caucasians showing
relationships between insulin action and skeletal muscle membrane lipid composition (7, 8). The present data are unable to
define the cause for this insulin resistance or the effect of obesity
on insulin resistance. However, since membrane function is
central to most physiological processes, the current findings
have far reaching implications for possible causes of diabetes
and obesity.
Cell membranes are dynamic lipid bilayers which separate
the cell from the extracellular milieu and surround intracellular
organelles. The major component is phospholipid which consti-

Table 111. Correlation Table of Metabolic Determinants and Derived Fatty Acid Indices
Variable

Mean*

LFPInst

Log MI

Log MZ11

pFATI

BMI**

UI

Waist/thigh

C20-22

Elongase

A9

A5

LFPIns

1
2.3±1.1
0.45±0.02 -0.788d
0.92±0.01 -0.854d
28±1
0.649d
32.9±1.3
0.557d
1.7±0.2
0.555d
176.6±0.9 -0.371b
C20-22 polyunsaturated
22.7±0.3 -0.396b
Elongase activity (18:0/16:0) 0.85±0.0 -0.170
A9 activity (18:ln-9/18:0)
0.63±0.0 -0.108
A5 activity (20:4n-6/20:3n-6) 8.02±0.2 -0.589d

Log M
Log MZ
pFAT
BMI
Waist/thigh
Unsaturation index

1

0.789d

1
-0.558d -0.458c

-0.447" -0.408"

Pan et al.

1

-0.471c -0.490c
0.579d 1
0.214
0.369b -0.187 -0.306a -0.193

1

0.839d 1
0.296a 0.463c -0.169 -0.284a -0.245
0.129 0.069
1
0.190 0.137 -0.467c -0.422b -0.240
0.332a 0.275a 0.223 -0.032 -0.079 -0.592d
-0.219 -0.008
0.563d 0.451 -0.610d -0.576d -0.348" 0.421" 0.351l 0.365b -0.341a 1

Mean values are means±SEM. Other values as described in Table
2804

1

0.879d
0.572d

H1 ap

< 0.05; b p <

0.01; c p < 0.001; d p

<

0.0001.

b
0

r= -0.610 pcO.0001

r = 0.589 pcO.0001

r-

0

1.0

20.r

0

0.8

0
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60% of the plasma membrane and > 90% of some
organelle membranes such as mitochondria (34). Membranes
permit the maintenance of ionic gradients, potential differences
and modulate the passage of hormones, substrates, nutrients and
intracellular signals. As such, the fatty acid composition of
membrane phospholipids themselves are instrumental determinants of cellular metabolism. The current studies used total
muscle membranes. Isolation of subcellular membrane fraction
would doubtless provide even greater insight into the role of
membranes in insulin action and obesity.
NIDDM is a genetic disease that becomes manifest under
particular environmental conditions (27-30, 35, 36). The environmental component of NIDDM is demonstrated by the secular
trends in diabetes prevalence this century, particularly in developing societies (37, 38). Obesity has long been associated with
the development of NIDDM and along with diet composition,
may constitute one of the major "environmental" determinants
of the development of the disease. The incidence of NIDDM
in the Pima Indians is proportional to the degree of obesity as
well as the family history of the disease (27) consistent with
environmental and genetic causes. Obesity also correlates with
the degree of insulin resistance and it seems possible that the
impact of obesity on NIDDM may be mediated via insulin
resistance (22, 33). Membrane lipid composition has the potential to be influenced by both genetic and lifestyle factors and
therefore may be the focal point at which these factors act in
concert to determine insulin action. This could also be true for
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Elongase Activity (18:0/16:0)
Figure 2. Percentage body fat in relation to elongase activity. Elongase
activity was estimated from the product precursor ratio of the percentages of individual fatty acids 18:0/16:0.

Figure 1. Insulin-action (M; a)
and percentage body fat (b) in relation to AS desaturase activity.
The index of insulin-action at
physiological insulin level (M;
290 pmol/min.m2) was derived
from the hyperinsulinemic euglycemic clamp technique and is
expressed in terms of the number
of milligrams of glucose infused
per minute per kg of fat free mass
+ 17.7. Percentage body fat was
determined by hydrodensitometry.
A5 desaturase activity was estimated according to the fatty acid
product precursor ratio 20:4n-6/
20:3 n-6.

example if the activities of the enzymes controlling the formation of long-chain PUFA or their insertion into the structural
lipids of cell membranes, were under strong genetic influence.
In addition, dietary lipid profile (12, 39-41) and alcohol (42)
are environmental factors capable of modifying membrane lipid
composition.

With the exception of certain marine oils, the major dietary
fatty acids must all be substantially elongated and desaturated
to be transformed into the long chain PUFA that we have shown
to be associated with leanness and insulin sensitivity. In this
study, enzyme activities were determined indirectly by product
precursor ratios. A strong relationship was observed between
reduced A5 desaturase activity (20:4n-6/20:3n-6) and both reduced insulin action and increased adiposity. Both insulin action
and obesity are independently related to A5 and both obesity
and A5 independently correlate with M values. This means that
the strong relationship of the A5 to insulin resistance is not
merely an epiphenomenon of the effects of obesity and therefore
deserves consideration as part of the genetic predisposition to
insulin resistance (28). On the other hand, the C20-22 PUFA
and UI independently correlate with measures of insulin action
but not obesity. This could be due to effects of either genotype
or diet directly on insulin action.
The elongase activity ( 18:0/16:0), which inserts two carbon
units onto the fatty acid backbone, showed a relationship to
obesity but not to insulin action. The elongase enzyme is
thought to be ubiquitous throughout all fatty acid biosynthetic
pathways and it must work in concert with the desaturase enzymes as requisite steps between the major dietary n-6 and n3 fatty acids (linoleic and a-linolenic) and the formation of the
important long chain PUFA.
A9 desaturase, which inserts a double bond at carbon nine
of the fatty acid chain, was also associated with obesity but not
insulin action. This is a novel finding in humans but entirely
consistent with results in animal models of obesity (13).
Though the etiological significance of increased A9 desaturase
activity in obesity is unclear it may relate to an attempt to
compensate for major decreases in other desaturase enzymes in
order to maintain cell membrane fluidity within some regulated
range. Certainly there is clear evidence for major (and uncharacteristic) increases in the n-9 class of fatty acids during essential
(n-6 and/or n-3) fatty acid deficiencies (43, 44). Studies aimed
at measuring enzyme activity before and after intervention (resulting in both weight loss or weight gain) would be instructive
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regulation of numerous processes including appetite.
The overall control of the partitioning of dietary fats between storage and oxidation is not clear. However, work in

clear differences between the oxidation
are oxidized at much faster rates than are saturated fats. Alteration in
enzyme activities, as are here associated with obesity, would
favor an increased proportion of the less readily oxidized fatty
acids, and thus may cause, or at least exacerbate, the tendency
towards decreased fat oxidation in the obese. This study found
no relationship between lipid oxidation rate and phospholipid
fatty acid composition. This may reflect the fact that most of
the lipid for oxidation is coming from storage triglyceride and
the relationship of its fatty acid profile to that of muscle membrane phospholipid is unknown.

rodents has shown
rates

very

of different fatty acids (50). Longer-chain PUFA

most

highly unsatu-

rated and longest chain of any fatty acid found in skeletal muscle. It comprises the bulk proportion of total n-3 fatty acids.
Unless provided in the diet (primarily as marine oils), its precursors must be substantially elongated and desaturated to form
this fatty acid. One striking difference between the muscle phospholipid fatty acid composition in the Pima Indians and an
Australian, largely Caucasian, population (7) is the low percentage of long chain n-3 PUFA (22:6n-3: 1.2±0.1% versus

vSC)

; 4

sity-insulin action relationship while others are not. This is
consistent with the observations that insulin action has determinants that are independent of obesity (28) and that obesity bears
a complex relationship with insulin resistance (45).
Given the relationships between adiposity and phospholipid
biosynthetic enzyme activities what are the possible mechanisms which might subtend such relationships? Increases in ion
"leakage" and Na+/K+ ATPase activity, (i.e., increased
whole-body metabolic rate) have been directly associated with
increased PUFA content in comparative studies between endotherms and ectotherms (46, 47). In animals and humans, increasing the dietary polyunsaturated to saturated ratio resulted
in increased membrane unsaturation (12, 41) and increased
basal metabolic rate ( 10, 26). The effect of leaking membranes
may not be limited to energy expenditure. Leaking membranes
are the basis of spontaneous membrane depolarization which
may affect neuronal firing rates and in turn muscle gene expression affecting muscle fibre type (48, 49). Altered ion flux may
also influence central nervous system activity and hence the

Docosahexaenoic acid (22:6n-3) is the

N

r. 0

B

in elucidating whether altered A9 or desaturase activities are
the likely cause or effect in adiposity.
The results indicate that some aspects of fatty acid metabolism are of considerable importance in the well recognized obe-

2.5±0.7% in the Australian population). This finding

may re-

flect a very low dietary intake of n-3 in the Pima Indians.
However, among the Australian population even individuals
with little or no discernible n-3 intake (unpublished observa-

tions) had muscle membrane n-3 levels much higher than the
Pima study group. The low levels of n-3 in the Pimas may then
reflect a genetic reluctance to incorporate this important class
of fatty acids into membranes, thus predisposing this population
to the "syndromes of insulin resistance." Further to this point,
an intestinal fatty acid binding protein loci on chromosome 4q
has been significantly linked with insulin resistance in Pima
Indians (32). It is tempting to speculate that the "thrifty
gene(s)" (51, 52) may therefore include, those which control
the binding and uptake of certain fatty acids, the incorporation
of specific PUFA into membrane lipids, and/or regulation of

the production and activity of the enzymes that elongate and
desaturate fatty acids.
This study is unable to determine which are the cause and
effects in any of the relationships described. The possibility that
A5 desaturase activity could be part of the genetic regulation
of insulin resistance needs to be explored. Whether any effect
of diet on insulin resistance could be mediated through this
enzyme or the fatty acid levels it regulates deserves study. Finally, it is possible that obesity directly affects elongase and
A9 desaturase activity, but it should also be considered that
such alterations of activity might lead to obesity.
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